Literature DB >> 29063757

Surface Modification of Polysaccharide-Based Nanoparticles with PEG and Dextran and the Effects on Immune Cell Binding and Stimulatory Characteristics.

Denise Bamberger1, Dominika Hobernik2, Matthias Konhäuser1, Matthias Bros2, Peter R Wich1.   

Abstract

Surface modifications of nanoparticles can alter their physical and biological properties significantly. They effect particle aggregation, circulation times, and cellular uptake. This is particularly critical for the interaction with primary immune cells due to their important role in particle processing. We can show that the introduction of a hydrophilic PEG layer on the surface of the polysaccharide-based nanoparticles prevents unwanted aggregation under physiological conditions and decreases unspecific cell uptake in different primary immune cell types. The opposite effect can be observed with a parallel-performed introduction of a layer of low molecular weight dextran (3.5 and 5 kDa) on the particle surface (DEXylation) that encourages the nanoparticle uptake by antigen-presenting cells like macrophages and dendritic cells. Binding of DEXylated particles to these immune cells results in an upregulation of surface maturation markers and elevated production of proinflammatory cytokines, reflecting cell activation. Hence, DEXylated particles can potentially be used for passive targeting of antigen presenting cells with inherent adjuvant function for future immunotherapeutic applications.

Entities:  

Keywords:  DEXylation; PEGylation; acetalated dextran; dendritic cells; immune cells; macrophages; nanoparticles

Mesh:

Substances:

Year:  2017        PMID: 29063757     DOI: 10.1021/acs.molpharmaceut.7b00507

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  6 in total

1.  Injectable, Ribbon-Like Microconfetti Biopolymer Platform for Vaccine Applications.

Authors:  Kathryn M Moore; Cole J Batty; Rebeca T Stiepel; Christopher J Genito; Eric M Bachelder; Kristy M Ainslie
Journal:  ACS Appl Mater Interfaces       Date:  2020-08-24       Impact factor: 9.229

Review 2.  Retargeting adenoviruses for therapeutic applications and vaccines.

Authors:  Michael A Barry; Jeffrey D Rubin; Shao-Chia Lu
Journal:  FEBS Lett       Date:  2020-02-03       Impact factor: 4.124

Review 3.  Polysaccharide-based nanomedicines for cancer immunotherapy: A review.

Authors:  Yujun Zeng; Yufan Xiang; Ruilong Sheng; Helena Tomás; João Rodrigues; Zhongwei Gu; Hu Zhang; Qiyong Gong; Kui Luo
Journal:  Bioact Mater       Date:  2021-03-18

Review 4.  The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery.

Authors:  Matthias Bros; Lutz Nuhn; Johanna Simon; Lorna Moll; Volker Mailänder; Katharina Landfester; Stephan Grabbe
Journal:  Front Immunol       Date:  2018-08-02       Impact factor: 7.561

Review 5.  Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics.

Authors:  Minghai Zhang; Shanshan Cheng; Yue Jin; Nan Zhang; Yu Wang
Journal:  Clin Transl Med       Date:  2021-02

Review 6.  Glyconanomaterials for Human Virus Detection and Inhibition.

Authors:  Noelia Losada-Garcia; Carla Garcia-Sanz; Alicia Andreu; Trinidad Velasco-Torrijos; Jose M Palomo
Journal:  Nanomaterials (Basel)       Date:  2021-06-26       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.